The pilot study of the basic pharmacokinetic properties of pyrrolylcarnosine — the new pyrrolic derivative of dipeptide carnosine
https://doi.org/10.37489/2587-7836-2023-2-29-36
Abstract
The experimental study of the pharmacokinetic characteristics of a new pyrrole derivative of carnosine, pyrrolylcarnosine, was carried out. Based on the results of the experiment, the basic pharmacokinetic parameters of the drug are expected. The tissues and organs bioavailability was studied. The tropism of pyrrolylcarnosine to the organs of elimination and the ability of pyrrolylcarnosine to penetrate into the heart muscle tissue were shown.
About the Authors
D. A. AbaimovRussian Federation
Denis A. Abaimov - PhD, Cand. Sci. (Biology), Senior Researcher at the Laboratory of Hemorheology, Hemostasis and Pharmacokinetics with clinical and laboratory diagnostics
Moscow
Anastasiya V. Khutorova
Russian Federation
Anastasiya V. Khutorova - laboratory assistant-researcher of the Laboratory of Experimental and Translational Neurochemistry;
postgraduate student of the Department of Pharmacology of the Faculty of Fundamental Medicine
Moscow
A. K. Sariev
Russian Federation
Abrek K. Sariev - Dr. Sci (Med.), Professor, Leading Researcher, Laboratory of Pharmacokinetics and Metabolomic Analysis
Moscow
O. I. Kulikova
Russian Federation
Olga I. Kulikova - PhD, Cand. Sci. (Biology), Researcher at the Laboratory of Experimental and Translational Neurochemistry
Moscow
M. A. Belousova
Russian Federation
Margarita A. Belousova - PhD, Cand. Sci. (Med), Researcher of the Department of Pharmacology of the Faculty of Fundamental Medicine
Moscow
S. L. Stvolinsky
Russian Federation
Sergey L. Stvolinsky - Dr. Sci (Biology), Leading Researcher at the Laboratory of Experimental and Translational Neurochemistry
Moscow
V. A. Migulin
Russian Federation
Vasily A. Migulin - PhD, Cand. Chemical Sci., Researcher at the Laboratory of Heterocyclic Compounds
Moscow
T. N. Fedorova
Russian Federation
Tatiana N. Fedorova - Dr. Sci (Biology), Chief Researcher, Head of the Laboratory of Experimental and Translational Neurochemistry
Moscow
References
1. Berezhnoy DS, Stvolinsky SL, Lopachev AV, et al. Carnosine as an effective neuroprotector in brain pathology and potential neuromodulator in normal conditions. Amino Acids. 2019 Jan;51(1):139–150. DOI: 10.1007/s00726-018-2667-7.
2. Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013 Oct;93(4):1803–45. DOI: 10.1152/physrev.00039.2012.
3. Bhardwaj V, Gumber D, Abbot V, Dhiman S, Sharma P. Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics. Rsc Advances. 2015;5(20):15233–15266. DOI:10.1039/C4RA15710A
4. Каратеев А. Е. На пути к созданию новой генерации нестероидных противовоспалительных препаратов: амтолметин гуацил. Современная ревматология. 2014;(2):72–78. [Karateev AE. On the way toward designing next-generation nonsteroidal anti-inflammatory drugs: amtolmetin guacil. Sovremennaya revmatologiya = Modern Rheumatology Journa. 2014;(2):72–78. (In Russ).]. doi: 10.14412/1996-7012-2014-2-83-89.
5. Матвеев А.В., Крашенинников А.Е., Егорова Е.А. Современный взгляд на эффективность и безопасность кеторолака. РМЖ. Медицинское обозрение. 2018;(4):34–39. [Matveev AV, Krasheninnikov AE, Egorova EA. Modern view on the efficacy and safety of ketorolac. RMJ. Medical Review. 2018;(4):34–39. (In Russ).].
6. Солгалова А.С., Солдатов В.О., Першина М.А., Покровская Т.Г. Пирацетам и бетагистин: возможные механизмы эндотелиопротекции. Человек и его здоровье. 2018;(2):61–69. [Solgalova AS, Soldatov VO, Pershina MA, Pokrovskaya TG. Piracetam and betahistine: possible mechanisms of endothelioprotection. Humans and their health. 2018;(2):61–69. (In Russ).]. DOI: 10.21626/vestnik/2018-2/10.
7. Hanuman Reddy V, Mallikarjuna Reddy G, Thirupalu Reddy M, Rami Reddy YV. Microwave-assisted facile synthesis of trisubstituted pyrrole derivatives. Research on Chemical Intermediates. 2015;41:9805–9815. DOI: 10.1007/s11164-015-1966-9.
8. Tzankova D, Vladimirova S, Peikova L, Georgieva M. Synthesis of pyrrole and substituted pyrroles. Journal of Chemical Technology and Metallurgy. 2018;53(3):451–464. DOI: 10.2478/acph-2020-0026.
9. Патент 2 777 391 C1 Российская Федерация, МПК C07D403/12 A61K31/4178 A61P39/06 A61P25/00. Средство, обладающее антиоксидантной и нейропротекторной активностью. Заявитель и патентообладатель ФГБНУ НЦН. – № 2021133431; заявл. 17.11.2021; опубл. 03.08.2022; Бюл.№23. [Fedorova TN, Stvolinsky SL, Migulin VA, et al, inventors; SUBSTANCE WITH ANTIOXIDANT AND NEUROPROTECTOR ACTIVITY. Russia patent RU 2777391 C1., 2022. (In Russ).]. URL: https://patenton.ru/patent/RU2777391C1
10. Pegova A, Abe H, Boldyrev A. Hydrolysis of carnosine and related compounds by mammalian carnosinases. Comp Biochem Physiol B Biochem Mol Biol. 2000 Dec;127(4):443–6. DOI: 10.1016/s0305-0491(00)00279-0.
11. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ / Под общей редакцией члена-корреспондента РАМН, профессора Р. У. Хабриева. 2-изд., перераб. и доп. М.: ОАО «Издательство «Медицина», 2005. 832 с. [Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veshchestv. Under the general editorship of corresponding member of the Russian Academy of Sciences, Professor RU Khabriev. 2nd ed., reprint. and additional. Moscow: JSC "Publishing House "Medicine", 2005. (In Russ).].
12. Основы фармакокинетики / И.И. Мирошниченко. Москва: ГЭОТАР-МЕД, 2002 (ООО Момент) 185 с. [Miroshnichenko II. Osnovy farmakokinetiki. GEOTAR-Media, 2002. (In Russ).].
13. Фармакокинетика / Н.Н. Каркищенко, В.В. Хоронько, С.А. Сергеева, В.Н. Каркищенко; Под. ред. Г.И. Должич. Ростов-на-Дону: Феникс, 2001. 381 с. [Farmakokinetika. Karkishchenko NN, Khoronko VV, Sergeeva SA, Karkishchenko VN. / Ed by Dolzhich GI. Rostov-on-Don: Phoenix; 2001. (In Russ).].
14. Тюренков И.Н., Перфилова В.Н., Смирнова Л.А., и др. Фармакокинетические свойства нового производного ГАМК цитрокарда: распределение и тканевая биодоступность. Фармакокинетика и Фармакодинамика. 2012;(2):26–29. [Tyurenkov IN, Perfilova VN, Smirnova LA, et al. Pharmacokinetic properties of a new GABA citrocard derivative: distribution and tissue bioavailability. Farmakokinetika i farmakodinamika = Pharmacokinetics and pharmacodynamics. 2012;(2):26-29. (In Russ).]. DOI: 10.30906/0869-2092-2013-76-3-38-40.
Review
For citations:
Abaimov D.A., Khutorova A., Sariev A.K., Kulikova O.I., Belousova M.A., Stvolinsky S.L., Migulin V.A., Fedorova T.N. The pilot study of the basic pharmacokinetic properties of pyrrolylcarnosine — the new pyrrolic derivative of dipeptide carnosine. Pharmacokinetics and Pharmacodynamics. 2023;(2):29-36. (In Russ.) https://doi.org/10.37489/2587-7836-2023-2-29-36